⌘K
Loading ticker…
As of 2026-08-24, Fulgent Genetics, Inc. Common Stock (FLGT) has a 3-month relative strength percentile of 73 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.83×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
FLGT is held by 26 ETFs as of May 2026. Top owner: FNDA at 0.03% weight, $2M notional. Top 3 carry $6M.
Held by 53 ETFs · $47M across latest filings · largest weight 0.81% (XHS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FNDA | 0.03% | $2M | — |
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| ESML | 0.04% | $863K | +0.01 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.02% |
| $667K |
| — |
| SBIO | 0.36% | $584K | +0.05 pp |
| VTWV | 0.02% | $308K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $289K | — |
| GNOM | 0.36% | $200K | +0.10 pp |
Showing 10 of 26 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FLGT Jan avg: -2.92% median: -5.09% win: 25% σ: 12.49% n: 4 2022-04-12 → 2026-07-31 | FLGT Feb avg: -14.96% median: -7.70% win: 0% σ: 17.84% n: 4 2022-04-12 → 2026-07-31 | FLGT Mar avg: 1.13% median: -0.05% win: 50% σ: 6.69% n: 4 2022-04-12 → 2026-07-31 | FLGT Apr avg: -3.54% median: -4.46% win: 20% σ: 3.55% n: 5 2022-04-12 → 2026-07-31 | FLGT May avg: 14.83% median: 19.42% win: 80% σ: 14.56% n: 5 2022-04-12 → 2026-07-31 | FLGT Jun avg: -0.56% median: -4.05% win: 40% σ: 8.05% n: 5 2022-04-12 → 2026-07-31 | FLGT Jul avg: 0.69% median: 4.86% win: 60% σ: 16.99% n: 5 2022-04-12 → 2026-07-31 | FLGT Aug avg: -4.89% median: -10.68% win: 25% σ: 24.27% n: 4 2022-04-12 → 2026-07-31 (current) | FLGT Sep avg: -8.11% median: -7.99% win: 25% σ: 9.01% n: 4 2022-04-12 → 2026-07-31 | FLGT Oct avg: -2.12% median: -0.98% win: 25% σ: 6.04% n: 4 2022-04-12 → 2026-07-31 | FLGT Nov avg: 5.95% median: 3.36% win: 50% σ: 21.49% n: 4 2022-04-12 → 2026-07-31 | FLGT Dec avg: -5.83% median: -5.13% win: 50% σ: 10.54% n: 4 2022-04-12 → 2026-07-31 |